DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY

Scope & Guideline

Innovating Solutions for Modern Pharmaceutical Challenges

Introduction

Welcome to your portal for understanding DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, featuring guidelines for its aims and scope. Our guidelines cover trending and emerging topics, identifying the forefront of research. Additionally, we track declining topics, offering insights into areas experiencing reduced scholarly attention. Key highlights include highly cited topics and recently published papers, curated within these guidelines to assist you in navigating influential academic dialogues.
LanguageEnglish
ISSN0363-9045
PublisherTAYLOR & FRANCIS LTD
Support Open AccessNo
CountryUnited States
TypeJournal
Converge1974, from 1976 to 2024
AbbreviationDRUG DEV IND PHARM / Drug Dev. Ind. Pharm.
Frequency12 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
Address2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND

Aims and Scopes

The journal 'Drug Development and Industrial Pharmacy' focuses on advancing the field of pharmaceutical sciences with an emphasis on drug formulation, delivery systems, and industrial practices. It aims to bridge the gap between laboratory research and practical applications in the pharmaceutical industry.
  1. Drug Formulation and Delivery Systems:
    The journal emphasizes innovative drug formulation strategies, particularly those involving nanotechnology, to enhance drug solubility, stability, and bioavailability. This includes the development of nanoemulsions, liposomes, and polymeric nanoparticles for various therapeutic applications.
  2. Quality by Design (QbD) Approaches:
    A core focus is on the application of QbD principles in pharmaceutical development, which ensures that the quality of drug products is built into the formulation process, thereby enhancing product reliability and compliance with regulatory standards.
  3. Pharmacokinetics and Pharmacodynamics:
    Research published in the journal often explores the pharmacokinetic and pharmacodynamic profiles of novel formulations, providing insights into their efficacy and safety in clinical settings.
  4. Natural Products and Phytopharmaceuticals:
    The journal also highlights the use of natural products and phytochemicals in drug development, exploring their potential therapeutic effects and mechanisms of action.
  5. Analytical Methods in Drug Development:
    A significant emphasis is placed on the development and validation of analytical techniques for the characterization of drug formulations, ensuring their quality and performance through rigorous testing.
The journal has seen a rise in interest in several emerging themes, reflecting the latest advancements in drug development and industrial pharmacy practices. These trends highlight the journal's commitment to addressing contemporary challenges in the pharmaceutical field.
  1. Nanotechnology in Drug Delivery:
    There is a significant increase in research focusing on nanotechnology applications in drug delivery systems, including the use of nanocarriers, nanocrystals, and nanoemulsions to improve the pharmacokinetic profiles of drugs.
  2. Personalized Medicine and Targeted Therapies:
    Emerging themes include personalized medicine approaches that cater to individual patient needs, particularly in oncology and chronic diseases, where targeted therapies are becoming more prevalent.
  3. Regenerative Medicine and Drug Delivery Systems:
    The journal is increasingly publishing studies related to regenerative medicine, particularly involving novel drug delivery systems that enhance tissue repair and regeneration.
  4. Sustainable and Green Chemistry:
    There is a growing focus on sustainable practices in drug development, including the use of green chemistry principles to minimize environmental impact and improve the safety of pharmaceutical processes.
  5. Theranostics:
    The integration of therapeutic and diagnostic approaches, or theranostics, is gaining traction, with research exploring how combined therapies can enhance treatment efficacy and patient outcomes.

Declining or Waning

As the field of drug development evolves, certain themes within the journal's scope appear to be declining in prominence. These waning themes reflect shifts in research focus and the increasing prioritization of novel methodologies and technologies.
  1. Traditional Drug Formulation Techniques:
    There is a noticeable decrease in publications focusing on conventional drug formulation methods, such as simple mixing or granulation techniques, as the field shifts towards more sophisticated and technologically advanced approaches.
  2. Single-drug Formulations:
    Research on single-drug formulations is becoming less common, with a growing trend towards combination therapies and multi-drug delivery systems that can enhance treatment efficacy and reduce side effects.
  3. Basic Pharmacological Studies:
    While basic pharmacological studies remain important, there is a decline in the number of publications focusing solely on these aspects without integration into formulation development or delivery systems, as the journal increasingly prioritizes translational research.

Similar Journals

International Journal of Pharmaceutical Investigation

Advancing Pharmaceutical Science for a Healthier Tomorrow
Publisher: INPHARM ASSOC, PHCOG NETISSN: 2230-973XFrequency: 4 issues/year

International Journal of Pharmaceutical Investigation, published by INPHARM ASSOC, PHCOG NET, is a premier platform dedicated to advancing the field of pharmaceutical sciences. With the ISSN 2230-973X and E-ISSN 2230-9713, this journal serves as a vital resource for researchers, professionals, and students focused on drug development, formulation, and efficacy. By fostering a rich discourse on innovative pharmaceutical practices and research breakthroughs, the journal plays a critical role in enhancing global health outcomes through groundbreaking scholarly work. The absence of open access allows for selective dissemination of high-quality content, promoting rigorous peer-review processes that uphold academic integrity. Featuring articles that span a diverse range of topics within pharmaceutical sciences, the International Journal of Pharmaceutical Investigation is committed to supporting the ongoing evolution of this dynamic field, making it an essential read for anyone engaged in pharmaceutical research and development.

Istanbul Journal of Pharmacy

Empowering research, enhancing pharmacy practice.
Publisher: ISTANBUL UNIV, FAC PHARMACYISSN: Frequency: 3 issues/year

Istanbul Journal of Pharmacy, published by Istanbul University, Faculty of Pharmacy, is a pivotal platform dedicated to the advancement of pharmaceutical sciences and technology. This journal serves as a vital resource for researchers, professionals, and students alike, seeking to disseminate cutting-edge research, reviews, and innovative methodologies within the pharmaceutical discipline. With a commitment to open access, the journal aims to foster a collaborative environment that promotes information sharing and scholarly discourse. The Istanbul Journal of Pharmacy invites submissions that delve into diverse topics ranging from drug formulation to pharmacokinetics, ensuring that readers are equipped with the latest insights and discoveries in the field. This journal is positioned to enhance scientific communication within the pharmaceutical community and support the continuous evolution of pharmacy practice and education globally.

PHARMACEUTICAL RESEARCH

Unveiling breakthroughs in pharmaceutical sciences since 1984.
Publisher: SPRINGER/PLENUM PUBLISHERSISSN: 0724-8741Frequency: 12 issues/year

PHARMACEUTICAL RESEARCH, published by SPRINGER/PLENUM PUBLISHERS, is a leading journal in the ever-evolving field of pharmaceutical sciences. With an ISSN of 0724-8741 and an E-ISSN of 1573-904X, this journal has established itself as a critical hub for disseminating innovative research from 1984 to 2024. The journal holds impressive rankings in prominent categories, including Q2 in Biotechnology and Q2 in Pharmaceutical Science, reflecting its robust impact on the global scientific community. The journal aims to provide researchers, professionals, and students with high-quality articles that contribute significantly to the advancement of drug development and medicinal applications. Although it does not currently offer Open Access options, its rigorous peer-review process ensures that only the highest caliber research is published, making it a valuable resource for those seeking to stay at the forefront of pharmaceutical innovation.

EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES

Empowering Researchers to Transform Pharmaceutical Practices
Publisher: ELSEVIERISSN: 0928-0987Frequency: 15 issues/year

The European Journal of Pharmaceutical Sciences is a prestigious academic journal dedicated to advancing the field of pharmaceutical science. Published by Elsevier, the journal boasts an impressive impact factor and is categorized in the Q1 quartile for pharmaceutical science as of 2023, signifying its influence and reputation within the academic community. With a Scopus ranking of #20 out of 183 in the fields of pharmacology, toxicology, and pharmaceutics, the journal provides a vital platform for researchers and practitioners to disseminate innovative studies and groundbreaking research that push the boundaries of drug development and delivery. Based in the Netherlands and operating since 1993, the journal seeks to cover a broad scope of topics related to pharmaceutical sciences, encouraging rigorous evaluations and discussions that enhance the understanding and application of this critical field. The absence of open access underscores the commitment to maintaining high scholarly standards, while still offering avenues for libraries and institutions to provide access to cutting-edge research. As the journal converges towards its 2024 milestones, it continuously aims to foster a vibrant exchange of knowledge among its diverse readership, comprising committed researchers, professionals, and students.

Future Journal of Pharmaceutical Sciences

Pioneering Discoveries in Drug Development and Therapeutics
Publisher: SPRINGERISSN: 2314-7245Frequency: 1 issue/year

The Future Journal of Pharmaceutical Sciences, published by Springer, stands as a vital resource in the realm of pharmaceutical research and innovation. Recognized for its open access initiative since 2015, this journal promotes extensive dissemination of cutting-edge discoveries, fostering collaboration among researchers, industry professionals, and students alike. With an ISSN of 2314-7245 and an E-ISSN of 2314-7253, it aims to bridge the gap between laboratory research and practical applications in the pharmaceutical sciences. Although specific metrics like HIndex and Scopus ranks are currently unavailable, the journal's commitment to high-quality, peer-reviewed content positions it as a promising platform for advancing pharmaceutical science. By engaging with this journal, contributors and readers can participate in the vibrant discourse shaping the future of drug development, therapeutic strategies, and healthcare solutions.

DARU-Journal of Pharmaceutical Sciences

Fostering open access to transformative pharmaceutical research.
Publisher: SPRINGER INT PUBL AGISSN: Frequency: 2 issues/year

DARU-Journal of Pharmaceutical Sciences is a leading peer-reviewed journal published by SPRINGER INT PUBL AG that focuses on the dynamic and rapidly evolving fields of pharmaceutical sciences, including drug discovery, pharmacology, and toxicology. With an impressive Q2 ranking in both Drug Discovery and Miscellaneous Medicine categories for 2023, this journal stands out as a vital resource for researchers, professionals, and students alike, offering a platform for significant contributions to the scientific community. Covering a comprehensive scope from 2000 to 2024 and indexed by Scopus, the journal ranks within the top percentile in its field, with a ranking of #66/313 in Pharmacology and #34/157 in Drug Discovery, reaffirming its impact and relevance. The journal promotes open access to foster widespread dissemination of knowledge in pharmaceutical sciences, ultimately aiming to bridge the gap between research and clinical applications. For those looking to stay at the forefront of pharmaceutical innovation, DARU represents an invaluable connection to the latest studies and breakthrough findings.

Journal of Research in Pharmacy

Pioneering Insights in Pharmacological Research
Publisher: MARMARA UNIVISSN: 2630-6344Frequency: 4 issues/year

Journal of Research in Pharmacy, published by Marmara University, serves as a pivotal platform for the dissemination of innovative research in the field of pharmacology and pharmaceutical sciences. With an ISSN of 2630-6344 and an E-ISSN of the same, this journal is dedicated to publishing high-quality research spanning various aspects of pharmacology, toxicology, and pharmaceutics. The journal, categorized in Q3 for both pharmacology (medical) and miscellaneous pharmacology, toxicology, and pharmaceutics in 2023, showcases the ongoing evolution of these disciplines amid growing scientific inquiry. As of now, it ranks #56/80 in general pharmacology, toxicology and pharmaceutics, spotlighting its relevance within the academic community. Although it operates under a traditional access model, the journal is committed to providing researchers, professionals, and students with a comprehensive understanding of contemporary challenges and innovations in pharmacy research. Established in 2019, it continues to foster academic dialogue and contribute significantly to the advancement of pharmacological sciences until at least 2024. For all interested in cutting-edge pharmaceutical research, this journal presents an invaluable resource from its base in Istanbul, Turkey.

Indonesian Journal of Pharmacy

Bridging research and practice in the pharmaceutical sciences.
Publisher: UNIV GADJAH MADA, FAC FARMASIISSN: 2338-9486Frequency: 4 issues/year

Indonesian Journal of Pharmacy (ISSN: 2338-9486; E-ISSN: 2338-9427), published by UNIV GADJAH MADA, FAC FARMASI, stands as a significant platform for disseminating pioneering research in the field of pharmacy and pharmacology. Since its transition to an Open Access format in 2011, the journal has enhanced its visibility and accessibility, catering to a global audience of researchers, practitioners, and students. With a commendable Q3 category ranking in Pharmaceutical Science, Pharmacology, and Pharmacy for 2023, along with its respectable Scopus ranks, it provides valuable insights and advancements in the pharmaceutical sciences, particularly relevant to the Indonesian context and beyond. The journal not only supports the academic community but also contributes to the enhancement of healthcare practices through rigorous peer-reviewed publications. By fostering knowledge exchange and collaboration, the Indonesian Journal of Pharmacy aims to play a pivotal role in advancing research and development in pharmacy-related disciplines.

SCIENTIA PHARMACEUTICA

Empowering researchers with open access to cutting-edge findings.
Publisher: MDPIISSN: Frequency: 4 issues/year

SCIENTIA PHARMACEUTICA, published by MDPI in Switzerland, is a leading open access journal dedicated to advancing the field of pharmaceutical sciences since 2006. With a focus on pharmacology, toxicology, and pharmaceutics, this journal plays a pivotal role in disseminating high-quality research and innovative findings. It boasts an impressive impact factor and is ranked in the second quartile (Q2) for Pharmaceutical Science, signifying its influence within the academic community, aided by a Scopus ranking of 74 out of 183 journals in the same category. SCIENTIA PHARMACEUTICA invites original research articles, reviews, and notes that contribute to the understanding and development of pharmaceutical science, making it an essential resource for researchers, professionals, and students alike seeking to stay at the forefront of this continuously evolving field. For those interested in broadening their knowledge and sharing insights, the journal ensures wide accessibility, supporting the open access model for maximum outreach.

PHARMACIA

Advancing pharmaceutical knowledge for a healthier tomorrow.
Publisher: PENSOFT PUBLISHERSISSN: 0428-0296Frequency: 4 issues/year

PHARMACIA is a distinguished open-access journal, published by PENSOFT PUBLISHERS, that has been a pivotal platform for advancing the field of pharmaceutical sciences since 2007. This journal, with ISSN 0428-0296 and E-ISSN 2603-557X, is based in Bulgaria and continues to publish high-quality research and reviews relevant to pharmacy, pharmacology, and toxicology. Recognized in the Q3 category for Pharmaceutical Sciences and Pharmacology (medical), as well as Q2 in Pharmacy according to the latest rankings, PHARMACIA is celebrated for its commitment to fostering knowledge dissemination and innovation in drug development, therapeutic approaches, and pharmacological research. With a Scopus rank of #17 in Pharmacy and recognition in various health professions, the journal attracts contributions from researchers, professionals, and students seeking to impact the pharmaceutical landscape. Its convenient open-access format ensures that articles are readily available to a global audience, encouraging collaboration and advancement in the life sciences.